25 XP   0   0   10

Cabaletta Bio Inc
Buy, Hold or Sell?

Let's analyse Cabaletta Bio Inc together

PenkeI guess you are interested in Cabaletta Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cabaletta Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cabaletta Bio Inc

I send you an email if I find something interesting about Cabaletta Bio Inc.

Quick analysis of Cabaletta Bio Inc (30 sec.)










What can you expect buying and holding a share of Cabaletta Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.5%

What is your share worth?

Current worth
$4.90
Expected worth in 1 year
$7.63
How sure are you?
36.4%

+ What do you gain per year?

Total Gains per Share
$2.73
Return On Investment
20.5%

For what price can you sell your share?

Current Price per Share
$13.34
Expected price per share
$11.80 - $19.11
How sure are you?
50%

1. Valuation of Cabaletta Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$13.34

Intrinsic Value Per Share

$-14.17 - $-16.66

Total Value Per Share

$-9.28 - $-11.76

2. Growth of Cabaletta Bio Inc (5 min.)




Is Cabaletta Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$236.1m$98.1m$67.5m40.8%

How much money is Cabaletta Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$16.6m-$12.9m-$3.7m-22.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Cabaletta Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#222 / 1016

Most Revenue
#888 / 1016

Most Profit
#654 / 1016

Most Efficient
#332 / 1016

What can you expect buying and holding a share of Cabaletta Bio Inc? (5 min.)

Welcome investor! Cabaletta Bio Inc's management wants to use your money to grow the business. In return you get a share of Cabaletta Bio Inc.

What can you expect buying and holding a share of Cabaletta Bio Inc?

First you should know what it really means to hold a share of Cabaletta Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Cabaletta Bio Inc is $13.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cabaletta Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cabaletta Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.90. Based on the TTM, the Book Value Change Per Share is $0.68 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cabaletta Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-3.2%-0.35-2.6%-0.27-2.1%-0.23-1.7%-0.22-1.7%
Usd Book Value Change Per Share1.5611.7%0.685.1%-0.07-0.5%0.261.9%0.221.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.010.1%
Usd Total Gains Per Share1.5611.7%0.685.1%-0.07-0.5%0.272.0%0.231.7%
Usd Price Per Share22.70-14.78-3.25-8.17-7.43-
Price to Earnings Ratio-13.11--10.33--2.67--9.11--8.28-
Price-to-Total Gains Ratio14.55--16.11-1.85--26.57--26.57-
Price to Book Ratio4.64-4.28-1.52-3.04-2.77-
Price-to-Total Gains Ratio14.55--16.11-1.85--26.57--26.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.34
Number of shares74
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.680.26
Usd Total Gains Per Share0.680.27
Gains per Quarter (74 shares)50.5019.71
Gains per Year (74 shares)201.9978.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1020219237669
204043946151148
306065969227227
4080879812303306
501010100015379385
601212120219454464
701414140422530543
801616160625606622
901818180828682701
1002020201031757780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.012.01.035.0%8.013.01.036.4%8.013.01.036.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.021.04.5%1.00.021.04.5%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.012.01.035.0%8.013.01.036.4%8.013.01.036.4%

Fundamentals of Cabaletta Bio Inc

About Cabaletta Bio Inc

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, which is in Phase I/II clinical trial for the treatment of mucosal pemphigus vulgaris; and MuSK-CAART, an investigational cell therapy that is in Phase I/II clinical trial for treating patients with anti- muscle-specific kinase antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-11 03:15:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cabaletta Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cabaletta Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cabaletta Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-55,695,000.0%+55,695,000.0%
5Y-55,695,000.0%10Y-50,631,818.2%-5,063,181.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y-55,695,000.0%-438.4%-55,694,561.6%
10Y-50,631,818.2%-605.5%-50,631,212.7%
1.1.2. Return on Assets

Shows how efficient Cabaletta Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • -8.2% Return on Assets means that Cabaletta Bio Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cabaletta Bio Inc:

  • The MRQ is -8.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-10.0%+1.7%
TTM-10.0%YOY-12.2%+2.2%
TTM-10.0%5Y-8.7%-1.2%
5Y-8.7%10Y-9.4%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.2%-13.5%+5.3%
TTM-10.0%-12.9%+2.9%
YOY-12.2%-11.8%-0.4%
5Y-8.7%-14.1%+5.4%
10Y-9.4%-16.0%+6.6%
1.1.3. Return on Equity

Shows how efficient Cabaletta Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • -8.8% Return on Equity means Cabaletta Bio Inc generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cabaletta Bio Inc:

  • The MRQ is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-10.9%+2.0%
TTM-10.9%YOY-13.1%+2.3%
TTM-10.9%5Y-8.7%-2.2%
5Y-8.7%10Y-7.9%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-16.9%+8.1%
TTM-10.9%-16.1%+5.2%
YOY-13.1%-15.1%+2.0%
5Y-8.7%-19.9%+11.2%
10Y-7.9%-20.9%+13.0%

1.2. Operating Efficiency of Cabaletta Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cabaletta Bio Inc is operating .

  • Measures how much profit Cabaletta Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cabaletta Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-55,725,000.0%+55,725,000.0%
5Y-55,725,000.0%10Y-50,659,090.9%-5,065,909.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y-55,725,000.0%-477.4%-55,724,522.6%
10Y-50,659,090.9%-625.6%-50,658,465.3%
1.2.2. Operating Ratio

Measures how efficient Cabaletta Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cabaletta Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y557,250.000-557,250.000
5Y557,250.00010Y506,590.909+50,659.091
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y557,250.0005.679+557,244.321
10Y506,590.9097.894+506,583.015

1.3. Liquidity of Cabaletta Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cabaletta Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 15.29 means the company has $15.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cabaletta Bio Inc:

  • The MRQ is 15.286. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.541. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.286TTM15.541-0.255
TTM15.541YOY14.491+1.050
TTM15.5415Y23.940-8.399
5Y23.94010Y25.041-1.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.2863.914+11.372
TTM15.5414.220+11.321
YOY14.4915.388+9.103
5Y23.9406.045+17.895
10Y25.0416.406+18.635
1.3.2. Quick Ratio

Measures if Cabaletta Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 18.09 means the company can pay off $18.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cabaletta Bio Inc:

  • The MRQ is 18.086. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.685. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ18.086TTM18.685-0.599
TTM18.685YOY19.604-0.919
TTM18.6855Y23.554-4.869
5Y23.55410Y23.004+0.550
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.0863.572+14.514
TTM18.6853.998+14.687
YOY19.6045.390+14.214
5Y23.5545.969+17.585
10Y23.0046.287+16.717

1.4. Solvency of Cabaletta Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cabaletta Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cabaletta Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Cabaletta Bio Inc assets are financed with 6.9% credit (debt) and the remaining percentage (100% - 6.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cabaletta Bio Inc:

  • The MRQ is 0.069. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.078. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.069TTM0.078-0.009
TTM0.078YOY0.074+0.004
TTM0.0785Y0.118-0.040
5Y0.11810Y0.168-0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0690.336-0.267
TTM0.0780.334-0.256
YOY0.0740.269-0.195
5Y0.1180.366-0.248
10Y0.1680.390-0.222
1.4.2. Debt to Equity Ratio

Measures if Cabaletta Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 7.4% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cabaletta Bio Inc:

  • The MRQ is 0.074. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.085. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.085-0.011
TTM0.085YOY0.080+0.005
TTM0.0855Y0.053+0.032
5Y0.05310Y0.048+0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.382-0.308
TTM0.0850.396-0.311
YOY0.0800.335-0.255
5Y0.0530.434-0.381
10Y0.0480.465-0.417

2. Market Valuation of Cabaletta Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cabaletta Bio Inc generates.

  • Above 15 is considered overpriced but always compare Cabaletta Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -13.11 means the investor is paying $-13.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cabaletta Bio Inc:

  • The EOD is -7.703. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.108. Based on the earnings, the company is expensive. -2
  • The TTM is -10.327. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.703MRQ-13.108+5.405
MRQ-13.108TTM-10.327-2.781
TTM-10.327YOY-2.669-7.657
TTM-10.3275Y-9.112-1.215
5Y-9.11210Y-8.284-0.828
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.703-2.259-5.444
MRQ-13.108-2.569-10.539
TTM-10.327-2.664-7.663
YOY-2.669-4.120+1.451
5Y-9.112-6.258-2.854
10Y-8.284-6.171-2.113
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cabaletta Bio Inc:

  • The EOD is -9.673. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.460. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.915. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.673MRQ-16.460+6.787
MRQ-16.460TTM-12.915-3.544
TTM-12.915YOY-3.148-9.767
TTM-12.9155Y-10.585-2.330
5Y-10.58510Y-9.623-0.962
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.673-2.924-6.749
MRQ-16.460-3.246-13.214
TTM-12.915-3.488-9.427
YOY-3.148-5.620+2.472
5Y-10.585-8.315-2.270
10Y-9.623-8.826-0.797
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cabaletta Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.64 means the investor is paying $4.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cabaletta Bio Inc:

  • The EOD is 2.725. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.636. Based on the equity, the company is fair priced.
  • The TTM is 4.282. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.725MRQ4.636-1.912
MRQ4.636TTM4.282+0.354
TTM4.282YOY1.522+2.760
TTM4.2825Y3.044+1.238
5Y3.04410Y2.767+0.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7251.851+0.874
MRQ4.6362.090+2.546
TTM4.2822.095+2.187
YOY1.5222.844-1.322
5Y3.0443.466-0.422
10Y2.7673.815-1.048
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cabaletta Bio Inc.

3.1. Institutions holding Cabaletta Bio Inc

Institutions are holding 101.537% of the shares of Cabaletta Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc9.13940.00264409005196680880.5344
2023-12-31Fred Alger Management, LLC6.89680.40753327132-932323-21.8883
2023-12-31Adage Capital Partners Gp LLC6.77140.1535326664500
2023-12-31State Street Corporation5.37810.00292594470106162869.2588
2023-09-30Deerfield Management Co4.85080.7847234011800
2023-12-31Vanguard Group Inc4.41930.001121319311638238.3239
2023-12-31Perceptive Advisors LLC4.15211.0149200305887056776.8719
2023-12-31Bain Capital Life Sciences Investors, LLC4.14584.3518200000000
2023-09-30VR Adviser, LLC4.09043.1615197325320.0001
2023-12-31COMMODORE CAPITAL LP3.93853.76861900000-625753-24.7749
2023-12-31T. Rowe Price Investment Management,Inc.3.79930.0271183285418328540
2023-09-30Redmile Group, LLC3.67781.2848177425240395329.4792
2023-12-31Jennison Associates LLC3.37180.0275162662820426114.3606
2023-12-31Amvescap Plc.2.89780.0076139794254389963.6852
2023-12-31Polar Capital Holdings PLC2.59110.1738125000012500000
2023-09-30Holocene Advisors, LP2.45230.0788118304611830460
2023-12-31Geode Capital Management, LLC1.56130.0018753176613048.8606
2023-12-31Wellington Management Company LLP1.11910.0023539876293306118.9545
2023-12-31T. Rowe Price Associates, Inc.1.0940.00165277655124503346.0659
2023-12-31Integral Health Asset Management, LLC1.07791.607652000019000057.5758
Total 77.42516.86237351151+8979825+24.0%

3.2. Funds holding Cabaletta Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Alger Small Cap Focus Composite4.65552.95692159156-342529-13.6919
2023-12-31Alger Small Cap Focus I4.65552.95692159156-342529-13.6919
2024-02-29SPDR® S&P Biotech ETF4.24090.56831966890367231.9026
2024-01-31Polar Capital Biotech S Inc2.69521.5732125000000
2024-02-29Vanguard Total Stock Mkt Idx Inv2.69220.0018124862100
2024-02-29PGIM Jennison Small Company A2.1870.7454101430117691221.1266
2024-02-29iShares Russell 2000 ETF1.78840.0304829459-136-0.0164
2024-02-29Invesco Dorsey Wright SmallCap Momt ETF1.24381.4684576846144752.5739
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.19320.012455337639890.7261
2024-02-29BlackRock Health Sciences Term Trust1.09190.594150639500
2023-12-31T. Rowe Price Small-Cap Value1.04240.10384834464834460
2023-12-31Jennison SMid Cap Core Equity0.93620.32914341774341770
2023-12-31T. Rowe Price Small-Cap Stock0.9280.10324303864303860
2023-12-31T. Rowe Price US Small-Cap Core Equity0.9280.1034303864303860
2024-02-29BlackRock Health Sciences Opps Inv A0.90540.113341992000
2023-11-30BGF World Healthscience A20.86130.0539947000
2024-02-29PGIM Jennison Health Sciences Z0.84480.499139181900
2023-12-31Jennison Health Sciences Equity0.84480.5446391819-516264-56.8521
2023-12-31Fidelity Small Cap Index0.73980.030634309244451.3126
2023-12-31Invesco Small Cap Core0.68820.4263191733191730
Total 35.162513.210516307888+1132654+6.9%

3.3. Insider Transactions

Insiders are holding 3.138% of the shares of Cabaletta Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-19Gwendolyn BinderSELL1100019.59
2023-12-19Gwendolyn BinderSELL1100021.89
2023-10-19Gwendolyn BinderSELL1100013.36
2023-09-19Gwendolyn BinderSELL1100017.57
2023-08-21Gwendolyn BinderSELL1100013.42
2023-07-19Gwendolyn BinderSELL1100013.82
2023-06-20Gwendolyn BinderSELL1100012.99
2023-05-19Gwendolyn BinderSELL2200011.81

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cabaletta Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5600.682+129%-0.070+104%0.256+510%0.223+601%
Book Value Per Share--4.8963.435+43%2.035+141%2.324+111%2.134+129%
Current Ratio--15.28615.541-2%14.491+5%23.940-36%25.041-39%
Debt To Asset Ratio--0.0690.078-12%0.074-6%0.118-42%0.168-59%
Debt To Equity Ratio--0.0740.085-13%0.080-8%0.053+40%0.048+54%
Dividend Per Share----0%-0%0.010-100%0.010-100%
Eps---0.433-0.351-19%-0.275-37%-0.232-46%-0.225-48%
Free Cash Flow Per Share---0.345-0.281-18%-0.253-27%-0.189-45%-0.175-49%
Free Cash Flow To Equity Per Share--1.5840.691+129%-0.082+105%0.215+638%0.239+563%
Gross Profit Margin--1.0161.004+1%1.000+2%1.001+2%1.001+2%
Intrinsic Value_10Y_max---16.659--------
Intrinsic Value_10Y_min---14.175--------
Intrinsic Value_1Y_max---1.061--------
Intrinsic Value_1Y_min---1.041--------
Intrinsic Value_3Y_max---3.651--------
Intrinsic Value_3Y_min---3.476--------
Intrinsic Value_5Y_max---6.800--------
Intrinsic Value_5Y_min---6.272--------
Market Cap643542944.000-70%1095084320.000712769640.000+54%156664596.000+599%394302717.600+178%358457016.000+205%
Net Profit Margin----0%-0%-556950.0000%-506318.1820%
Operating Margin----0%-0%-557250.0000%-506590.9090%
Operating Ratio----0%-0%557250.000-100%506590.909-100%
Pb Ratio2.725-70%4.6364.282+8%1.522+205%3.044+52%2.767+68%
Pe Ratio-7.703+41%-13.108-10.327-21%-2.669-80%-9.112-30%-8.284-37%
Price Per Share13.340-70%22.70014.775+54%3.248+599%8.174+178%7.430+205%
Price To Free Cash Flow Ratio-9.673+41%-16.460-12.915-22%-3.148-81%-10.585-36%-9.623-42%
Price To Total Gains Ratio8.549-70%14.548-16.113+211%1.850+686%-26.567+283%-26.567+283%
Quick Ratio--18.08618.685-3%19.604-8%23.554-23%23.004-21%
Return On Assets---0.082-0.100+21%-0.122+48%-0.087+6%-0.094+14%
Return On Equity---0.088-0.109+23%-0.131+49%-0.087-1%-0.079-10%
Total Gains Per Share--1.5600.682+129%-0.070+104%0.266+486%0.232+572%
Usd Book Value--236198000.000165728250.000+43%98161000.000+141%112116500.000+111%102948681.818+129%
Usd Book Value Change Per Share--1.5600.682+129%-0.070+104%0.256+510%0.223+601%
Usd Book Value Per Share--4.8963.435+43%2.035+141%2.324+111%2.134+129%
Usd Dividend Per Share----0%-0%0.010-100%0.010-100%
Usd Eps---0.433-0.351-19%-0.275-37%-0.232-46%-0.225-48%
Usd Free Cash Flow---16633000.000-13559000.000-18%-12208250.000-27%-9124350.000-45%-8430090.909-49%
Usd Free Cash Flow Per Share---0.345-0.281-18%-0.253-27%-0.189-45%-0.175-49%
Usd Free Cash Flow To Equity Per Share--1.5840.691+129%-0.082+105%0.215+638%0.239+563%
Usd Market Cap643542944.000-70%1095084320.000712769640.000+54%156664596.000+599%394302717.600+178%358457016.000+205%
Usd Price Per Share13.340-70%22.70014.775+54%3.248+599%8.174+178%7.430+205%
Usd Profit---20886000.000-16643250.000-20%-12902000.000-38%-10737600.000-49%-10269681.818-51%
Usd Revenue----0%-0%0.050-100%0.045-100%
Usd Total Gains Per Share--1.5600.682+129%-0.070+104%0.266+486%0.232+572%
 EOD+2 -6MRQTTM+20 -10YOY+21 -95Y+19 -1510Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of Cabaletta Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.703
Price to Book Ratio (EOD)Between0-12.725
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than118.086
Current Ratio (MRQ)Greater than115.286
Debt to Asset Ratio (MRQ)Less than10.069
Debt to Equity Ratio (MRQ)Less than10.074
Return on Equity (MRQ)Greater than0.15-0.088
Return on Assets (MRQ)Greater than0.05-0.082
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Cabaletta Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.514
Ma 20Greater thanMa 5016.637
Ma 50Greater thanMa 10019.819
Ma 100Greater thanMa 20020.103
OpenGreater thanClose13.900
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets253,650
Total Liabilities17,452
Total Stockholder Equity236,198
 As reported
Total Liabilities 17,452
Total Stockholder Equity+ 236,198
Total Assets = 253,650

Assets

Total Assets253,650
Total Current Assets244,490
Long-term Assets9,160
Total Current Assets
Cash And Cash Equivalents 193,238
Short-term Investments 48,011
Other Current Assets 3,241
Total Current Assets  (as reported)244,490
Total Current Assets  (calculated)244,490
+/-0
Long-term Assets
Property Plant Equipment 7,451
Long-term Assets Other 1,709
Long-term Assets  (as reported)9,160
Long-term Assets  (calculated)9,160
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities15,994
Long-term Liabilities1,458
Total Stockholder Equity236,198
Total Current Liabilities
Short-term Debt 3,560
Accounts payable 4,547
Other Current Liabilities 7,887
Total Current Liabilities  (as reported)15,994
Total Current Liabilities  (calculated)15,994
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,458
Long-term Liabilities  (as reported)1,458
Long-term Liabilities  (calculated)1,458
+/-0
Total Stockholder Equity
Retained Earnings -233,237
Accumulated Other Comprehensive Income 39
Other Stockholders Equity 469,396
Total Stockholder Equity (as reported)236,198
Total Stockholder Equity (calculated)236,198
+/-0
Other
Cash and Short Term Investments 241,249
Common Stock Shares Outstanding 44,435
Liabilities and Stockholders Equity 253,650
Net Debt -188,220
Net Invested Capital 236,198
Net Working Capital 228,496
Property Plant and Equipment Gross 11,246
Short Long Term Debt Total 5,018



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
34,174
34,174
77,836
77,836
74,943
141,468
134,965
127,898
121,770
114,724
107,283
106,930
122,638
126,336
113,655
102,016
91,675
116,968
103,447
184,637
173,287
253,650
253,650173,287184,637103,447116,96891,675102,016113,655126,336122,638106,930107,283114,724121,770127,898134,965141,46874,94377,83677,83634,17434,174
   > Total Current Assets 
33,994
33,994
76,322
76,322
71,749
140,552
134,122
123,471
119,218
113,535
105,756
105,015
120,852
124,541
111,439
98,745
88,175
108,834
95,734
177,572
166,178
244,490
244,490166,178177,57295,734108,83488,17598,745111,439124,541120,852105,015105,756113,535119,218123,471134,122140,55271,74976,32276,32233,99433,994
       Cash And Cash Equivalents 
33,017
33,017
75,258
75,258
71,041
136,204
131,003
112,097
108,679
101,429
97,277
99,495
118,260
122,222
59,553
47,169
61,163
81,607
93,845
128,072
115,501
193,238
193,238115,501128,07293,84581,60761,16347,16959,553122,222118,26099,49597,277101,429108,679112,097131,003136,20471,04175,25875,25833,01733,017
       Short-term Investments 
0
0
0
0
0
0
0
7,698
8,062
7,233
4,751
3,313
1,000
0
49,660
49,637
24,732
24,940
0
48,256
48,890
48,011
48,01148,89048,256024,94024,73249,63749,66001,0003,3134,7517,2338,0627,6980000000
       Other Current Assets 
884
977
884
1,064
708
4,348
3,119
3,676
2,477
4,873
3,728
2,207
1,592
2,319
2,226
1,939
2,280
2,287
1,889
1,244
1,787
3,241
3,2411,7871,2441,8892,2872,2801,9392,2262,3191,5922,2073,7284,8732,4773,6763,1194,3487081,064884977884
   > Long-term Assets 
0
180
0
1,514
3,194
916
843
4,427
2,552
1,189
1,527
1,915
1,786
1,795
2,216
3,271
3,500
8,134
7,713
7,065
7,109
9,160
9,1607,1097,0657,7138,1343,5003,2712,2161,7951,7861,9151,5271,1892,5524,4278439163,1941,51401800
       Property Plant Equipment 
0
0
359
359
540
815
739
806
980
890
1,227
1,597
1,462
1,438
1,231
2,306
2,811
7,569
7,132
6,380
6,125
7,451
7,4516,1256,3807,1327,5692,8112,3061,2311,4381,4621,5971,22789098080673981554035935900
       Long Term Investments 
0
0
0
0
0
0
0
3,383
1,333
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,3333,3830000000
       Long-term Assets Other 
0
180
0
1,155
2,654
101
104
238
239
299
300
318
324
357
985
965
689
565
581
685
984
1,709
1,7099846855815656899659853573243183002992392381041012,6541,15501800
> Total Liabilities 
943
44,864
1,876
1,876
101,018
3,147
3,256
3,263
4,265
5,180
3,969
5,601
6,023
8,380
6,935
6,486
5,801
12,448
11,796
10,496
12,364
17,452
17,45212,36410,49611,79612,4485,8016,4866,9358,3806,0235,6013,9695,1804,2653,2633,2563,147101,0181,8761,87644,864943
   > Total Current Liabilities 
943
943
1,876
1,876
3,064
3,147
3,256
3,263
4,265
5,180
3,969
5,601
6,023
8,380
6,935
6,486
5,801
9,489
9,305
8,482
10,616
15,994
15,99410,6168,4829,3059,4895,8016,4866,9358,3806,0235,6013,9695,1804,2653,2633,2563,1473,0641,8761,876943943
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,179
2,181
2,182
2,522
3,560
3,5602,5222,1822,1812,17900000000000000000
       Accounts payable 
603
603
483
483
1,154
920
1,991
991
953
1,243
1,270
2,374
1,707
2,333
3,910
2,451
1,333
2,463
3,955
2,341
3,620
4,547
4,5473,6202,3413,9552,4631,3332,4513,9102,3331,7072,3741,2701,2439539911,9919201,154483483603603
       Other Current Liabilities 
10
340
305
1,393
1,910
2,227
1,265
2,272
3,312
3,937
2,699
3,227
4,316
6,047
3,025
4,035
4,468
4,847
3,169
20
30
7,887
7,88730203,1694,8474,4684,0353,0256,0474,3163,2272,6993,9373,3122,2721,2652,2271,9101,39330534010
   > Long-term Liabilities 
0
43,921
0
483
97,954
920
1,991
991
953
1,243
1,270
2,374
1,707
2,333
3,910
2,451
1,333
2,959
2,491
2,014
1,748
1,458
1,4581,7482,0142,4912,9591,3332,4513,9102,3331,7072,3741,2701,2439539911,99192097,954483043,9210
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,959
2,491
2,014
1,748
1,458
1,4581,7482,0142,4912,95900000000000000000
> Total Stockholder Equity
-10,690
-10,690
-21,994
75,960
-26,075
138,321
131,709
124,635
117,505
109,544
103,314
101,329
116,615
117,956
106,720
95,530
85,874
104,520
91,651
174,141
160,923
236,198
236,198160,923174,14191,651104,52085,87495,530106,720117,956116,615101,329103,314109,544117,505124,635131,709138,321-26,07575,960-21,994-10,690-10,690
   Common Stock0000000000000000000000
   Retained Earnings -233,237-212,351-195,903-181,416-165,562-149,870-138,443-125,533-112,587-98,699-87,139-76,000-66,298-56,989-48,596-40,444-32,959-27,556-21,994-21,994-12,452-12,452
   Capital Surplus 
0
0
0
0
1,481
171,280
172,153
0
0
175,836
179,311
188,467
215,314
0
0
0
235,953
270,129
273,067
0
0
0
000273,067270,129235,953000215,314188,467179,311175,83600172,153171,2801,4810000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
1,762
0
97,954
-96,473
171,280
172,153
173,220
174,482
175,836
179,311
188,467
215,314
230,543
232,405
234,222
235,953
270,129
273,067
370,047
373,295
469,396
469,396373,295370,047273,067270,129235,953234,222232,405230,543215,314188,467179,311175,836174,482173,220172,153171,280-96,47397,95401,7620



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,426
Gross Profit-1,426-1,426
 
Operating Income (+$)
Gross Profit-1,426
Operating Expense-73,234
Operating Income-74,660-74,660
 
Operating Expense (+$)
Research Development55,424
Selling General Administrative19,236
Selling And Marketing Expenses1,426
Operating Expense73,23476,086
 
Net Interest Income (+$)
Interest Income6,985
Interest Expense-0
Other Finance Cost-0
Net Interest Income6,985
 
Pretax Income (+$)
Operating Income-74,660
Net Interest Income6,985
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-67,675-81,645
EBIT - interestExpense = -74,660
-67,675
-67,675
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-74,660-67,675
Earnings Before Interest and Taxes (EBITDA)-73,234
 
After tax Income (+$)
Income Before Tax-67,675
Tax Provision-0
Net Income From Continuing Ops-67,675-67,675
Net Income-67,675
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses74,660
Total Other Income/Expenses Net6,985-6,985
 

Technical Analysis of Cabaletta Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cabaletta Bio Inc. The general trend of Cabaletta Bio Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cabaletta Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cabaletta Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15.80 < 19.04 < 19.11.

The bearish price targets are: 12.12 > 11.88 > 11.80.

Tweet this
Cabaletta Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cabaletta Bio Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cabaletta Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cabaletta Bio Inc. The current macd is -1.2911357.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cabaletta Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cabaletta Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cabaletta Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cabaletta Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartCabaletta Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cabaletta Bio Inc. The current adx is 27.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cabaletta Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Cabaletta Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cabaletta Bio Inc. The current sar is 18.24.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cabaletta Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cabaletta Bio Inc. The current rsi is 25.51. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Cabaletta Bio Inc Daily Relative Strength Index (RSI) ChartCabaletta Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cabaletta Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cabaletta Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cabaletta Bio Inc Daily Stochastic Oscillator ChartCabaletta Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cabaletta Bio Inc. The current cci is -256.73213353.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Cabaletta Bio Inc Daily Commodity Channel Index (CCI) ChartCabaletta Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cabaletta Bio Inc. The current cmo is -59.22601896.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cabaletta Bio Inc Daily Chande Momentum Oscillator (CMO) ChartCabaletta Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cabaletta Bio Inc. The current willr is -95.63758389.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cabaletta Bio Inc Daily Williams %R ChartCabaletta Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cabaletta Bio Inc.

Cabaletta Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cabaletta Bio Inc. The current atr is 1.20186907.

Cabaletta Bio Inc Daily Average True Range (ATR) ChartCabaletta Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cabaletta Bio Inc. The current obv is 77,031,589.

Cabaletta Bio Inc Daily On-Balance Volume (OBV) ChartCabaletta Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cabaletta Bio Inc. The current mfi is 35.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cabaletta Bio Inc Daily Money Flow Index (MFI) ChartCabaletta Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cabaletta Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Cabaletta Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cabaletta Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.514
Ma 20Greater thanMa 5016.637
Ma 50Greater thanMa 10019.819
Ma 100Greater thanMa 20020.103
OpenGreater thanClose13.900
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cabaletta Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Cabaletta Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cabaletta Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cabaletta Bio Inc

I send you an email if I find something interesting about Cabaletta Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cabaletta Bio Inc.

Receive notifications about Cabaletta Bio Inc in your mailbox!